Literature DB >> 11083651

Bactericidal activities of antibiotics against intracellular Francisella tularensis.

M Maurin1, N F Mersali, D Raoult.   

Abstract

MICs of many antibiotics for Francisella tularensis are low in axenic medium, whereas only aminoglycosides, tetracyclines, and fluoroquinolones are useful in treating tularemic patients. In an in vitro cell system, only these antibiotics, rifampin, and telithromycin were bactericidal against intracellular F. tularensis. These results correlate better with clinical data than MIC data do.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11083651      PMCID： PMC90216          DOI： 10.1128/AAC.44.12.3428-3431.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  33 in total

1.  The uptake and intracellular accumulation of aminoglycoside antibiotics in lysosomes of cultured rat fibroblasts.

Authors:  P Tulkens; A Trouet
Journal:  Biochem Pharmacol       Date:  1978-02-15       Impact factor: 5.858

2.  Molecular evolution of rifampicin resistance in Streptococcus pneumoniae.

Authors:  M Enright; P Zawadski; P Pickerill; C G Dowson
Journal:  Microb Drug Resist       Date:  1998       Impact factor: 3.431

3.  Uptake and intracellular localization of kanamycin and gentamycin in the lysosomes of cultured fibroblasts.

Authors:  P Tulkens; A Trouet
Journal:  Arch Int Physiol Biochim       Date:  1974-12

Review 4.  Tularemia: a 30-year experience with 88 cases.

Authors:  M E Evans; D W Gregory; W Schaffner; Z A McGee
Journal:  Medicine (Baltimore)       Date:  1985-07       Impact factor: 1.889

5.  Tick-borne tularemia. An outbreak of lymphadenopathy in children.

Authors:  L E Markowitz; N A Hynes; P de la Cruz; E Campos; J M Barbaree; B D Plikaytis; D Mosier; A F Kaufmann
Journal:  JAMA       Date:  1985 Nov 22-29       Impact factor: 56.272

6.  Treatment of tularemia, including pulmonary tularemia, with gentamicin.

Authors:  W L Mason; H T Eigelsbach; S F Little; J H Bates
Journal:  Am Rev Respir Dis       Date:  1980-01

7.  In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin.

Authors:  H Syrjälä; R Schildt; S Räisäinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

8.  In vitro interactions between rabbit alveolar macrophages and Pasteurella tularensis.

Authors:  J E Nutter; Q N Myrvik
Journal:  J Bacteriol       Date:  1966-09       Impact factor: 3.490

9.  Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth.

Authors:  C N Baker; D G Hollis; C Thornsberry
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

10.  Autoradiographic evidence for penetration of 3H-ceftriaxone (Rocephin) into cells of spleen, liver and kidney of mice.

Authors:  H Kuhn; P Angehrn; L Havas
Journal:  Chemotherapy       Date:  1986       Impact factor: 2.544
View more
  23 in total

Review 1.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Francisella novicida bacteremia after a near-drowning accident.

Authors:  Meghan Brett; Avanthi Doppalapudi; Laurel B Respicio-Kingry; Debra Myers; Brigitte Husband; Kerry Pollard; Paul Mead; Jeannine M Petersen; Cynthia J Whitener
Journal:  J Clin Microbiol       Date:  2012-06-12       Impact factor: 5.948

3.  In vitro and in vivo efficacy of florfenicol for treatment of Francisella asiatica infection in tilapia.

Authors:  Esteban Soto; Richard G Endris; John P Hawke
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

4.  Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection.

Authors:  Michael A Pammit; Varija N Budhavarapu; Erin K Raulie; Karl E Klose; Judy M Teale; Bernard P Arulanandam
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

5.  Tularemia and once-daily gentamicin.

Authors:  Ali Hassoun; Richard Spera; John Dunkel
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

6.  Persistence of Mycoplasma hyopneumoniae in experimentally infected pigs after marbofloxacin treatment and detection of mutations in the parC gene.

Authors:  J Le Carrou; M Laurentie; M Kobisch; A V Gautier-Bouchardon
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

7.  Cell extract-containing medium for culture of intracellular fastidious bacteria.

Authors:  Sudhir Singh; Malgorzata Kowalczewska; Sophie Edouard; Carole Eldin; Céline Perreal; Pascal Weber; Said Azza; Didier Raoult
Journal:  J Clin Microbiol       Date:  2013-06-05       Impact factor: 5.948

8.  The Polyaminoisoprenyl Potentiator NV716 Revives Old Disused Antibiotics against Intracellular Forms of Infection by Pseudomonas aeruginosa.

Authors:  Gang Wang; Jean-Michel Brunel; Jean-Michel Bolla; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

9.  Substituted diphenyl ethers as a broad-spectrum platform for the development of chemotherapeutics for the treatment of tularaemia.

Authors:  Kathleen England; Christopher am Ende; Hao Lu; Todd J Sullivan; Nicole L Marlenee; Richard A Bowen; Susan E Knudson; Dennis L Knudson; Peter J Tonge; Richard A Slayden
Journal:  J Antimicrob Chemother       Date:  2009-09-04       Impact factor: 5.790

Review 10.  Tularemia.

Authors:  Jill Ellis; Petra C F Oyston; Michael Green; Richard W Titball
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.